Medical News

RSS

Light Sciences Oncology announces Phase 2 trial of Aptocine in Benign Prostatic Hyperplasia

Light Sciences Oncology, Inc. (LSO) today announced the treatment of the first patients in a Phase 2 clinical trial of its innovative targeted drug treatment Aptocine(TM) (talaporfin sodium) in Benign Prostatic Hyperplasia (BPH). The Phase 2 trial expands the Aptocine BPH development program on the basis of a Phase 1 study at escalating light doses. In the open-label Phase 2 trial, Aptocine is being tested for safety and efficacy in 40 patients with lower urinary tract symptoms (LUTS) due to BPH. Aptocine is also in two Phase 3 clinical trials for solid tumors in the liver as well as preclinical development for prostate cancer.

19 Aug 2009

Researchers find connection between eye disease and arginase

Elevated levels of the enzyme arginase contribute to vascular eye damage and Medical College of Georgia researchers say therapies to normalize its levels could halt progression of potentially blinding diseases such as diabetic retinopathy.

19 Aug 2009

Gentium reports results from phase 3 trial of defibrotide for severe veno-occlusive disease

Gentium S.p.A. has announced top-line results from a historically controlled, multicenter, open label, Phase III trial designed to evaluate the safety and efficacy of 25 mg/kg/day of Defibrotide for the treatment of severe veno-occlusive disease (sVOD) in hematopoietic stem cell transplant (SCT) patients.

19 Aug 2009

Newly appointed NIH director includes global health on priority list

Francis Collins, the newly appointed director of the NIH on Monday outlined his top five priorities for the U.S. research agency during a town hall meeting with NIH staff, Science's blog "Science Insider" reports. Collins emphasized the agency's commitment to "high-throughput technologies," "translational research," "health care reform," "global health" and "empower[ing] the biomedical research community," the blog writes (Kaiser, 8/17).

19 Aug 2009

ImmunoCellular Therapeutics to participate in the Southern California Investor Conference

ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that it will participate in the Southern California Investor Conference being held in Newport Beach, CA, on Tuesday August 18, 2009.

19 Aug 2009

Norovirus controlled on cruise ship Marco Polo with vaporisation process by Activ8

The cruise ship Marco Polo, whose round-Britain cruise had to be cancelled because hundreds of passengers became ill with the vomiting bug Norovirus, has been totally disinfected by SitexOrbis' revolutionary infection control fogging service in just 5 hours at the Tilbury docks.

19 Aug 2009

Survey aims to better understand daily needs of unpaid caregivers of people with diabetes

Chevy Chase, MD-The Hormone Foundation, the public education affiliate of The Endocrine Society, in collaboration with the National Alliance for Caregiving, today released key findings from a first-of-its-kind survey (http://www.hormone.org/Public/diabetes_caregiver.cfm) aimed at better understanding the daily needs and struggles of unpaid caregivers of people with diabetes.

19 Aug 2009

Common-sense precautions for H1N1

Doctors and hospitals nationwide expect a surge in H1N1 influenza cases during the upcoming flu season. In a new video and the tips below, Yvonne Maldonado, MD, chief of infectious disease at Lucile Packard Children’s Hospital at Stanford, explains what every parent should know about H1N1 flu as children head back to school.

19 Aug 2009

Improving the health and well-being of U.S. lesbian, gay, bisexual and transgender teens

Research indicates that the social stigma that surrounds lesbian, gay, bisexual, and transgender (LGBT) teens leads to a variety of health risks such as substance use, risky sexual behaviors, eating disorders, suicidal ideation, and victimization.

19 Aug 2009

Omnia Biologics and Aparna Biosciences sign agreement on lentivirus drug development

Biologics contract manufacturer Omnia Biologics, Inc. (Omnia) (Rockville, MD) and drug development company Aparna Biosciences Corp. (AparnaBio) (Rockville, MD) today announced a deal for Omnia to provide AparnaBio with process development and production services. Omnia will provide lentiviral vector technical services as well as manufacture of research grade through cGMP grade materials.

19 Aug 2009

Neovasc reports Q2 2009 financials

"During the second quarter we continued to make significant progress in executing on our strategic initiatives adopted late last year," said Alexei Marko, chief executive officer of Neovasc. "We are especially pleased at the growing traction we are seeing in our tissue business, where our decision to focus on our specialty products and services is beginning to bear fruit, with increases in tissue sales already evident.

19 Aug 2009

The Parkinson's Disease Foundation and the Davis Phinney Foundation jointly fund new study

The Davis Phinney Foundation, a non-profit organization dedicated to improving the lives of people with Parkinson's disease (PD) today, announced that it has awarded four Parkinson's disease research centers with support to conduct a landmark study on the long-term changes in quality of life and mobility that occur in people with PD. The results of this research will help to advance the understanding of how interventions, such as exercise, impact changes in quality of life and mobility over the course of the disease.

19 Aug 2009

CEL-SCI expands work on current H1N1 virus vaccine

CEL-SCI Corporation has announced that it is expanding the scope of its work towards creating a novel treatment and vaccination against the current H1N1 virus, as well as a future mutated form in which the virus has acquired greater morbidity and mortality.

19 Aug 2009

Pennsylvania Governor signs new emergency medical services law

Governor Edward G. Rendell has signed into law Senate Bill 240, a measure to update and enhance Pennsylvania's existing Emergency Medical Services Act. The law was first enacted in 1985.

19 Aug 2009

Computed tomography angiography can identify abnormalities and injury beyond the pulmonary arteries

Children with clinically suspected pulmonary embolism (PE) are increasingly being evaluated with CT angiography (CTA). Even though many children ultimately test negative for PE, study results suggest that CTA is still valuable for this indication because it has the ability to accurately detect a variety of alternative diagnoses.

19 Aug 2009

Message from The White House: The President is not backing away from the public plan

"White House spokesman Robert Gibbs insists the Obama administration has not shifted its goals on health care reform or distanced itself from a government-run public insurance option." He told reporters today that stories indicating the Obama administration was backing away from including the public option in its push to overhaul the health system were "overblown."

19 Aug 2009

Seniors in U.S. overwhelmingly satisfied with their current Medicare coverage

Seniors in the U.S. are overwhelmingly satisfied with their current Medicare coverage, according to a survey released today by Silverlink Communications and Suffolk University in Boston. Of the more than 2,600 Medicare beneficiaries surveyed, more than 94% indicate that they are satisfied with their coverage, with just 6% expressing dissatisfaction.

19 Aug 2009

New "micropatterning" method useful in gene expression studies

Like oil and water, two water-based liquids can mingle without mixing in a new University of Michigan technology developed for biological experiments.

19 Aug 2009

Depression causes reduced function in the reward center of brain

Clinically depressed individuals are less capable of finding pleasure in activities they previously enjoyed, a recent study has proven. Research featured in the August 26 issue of the NeuroReport shows reduced brain function in the reward center of the brain in depressed individuals, when compared to healthy subjects.

19 Aug 2009

HealthFitness chosen to lead MillerCoor's health management strategy

Health Fitness Corporation, a leading provider of integrated employee health and productivity management solutions, today announced that MillerCoors recently awarded HealthFitness an expanded role in leading its company-wide health management strategy.

19 Aug 2009

Medical News

Light Sciences Oncology announces Phase 2 trial of Aptocine in Benign Prostatic Hyperplasia

Researchers find connection between eye disease and arginase

Gentium reports results from phase 3 trial of defibrotide for severe veno-occlusive disease

Newly appointed NIH director includes global health on priority list

ImmunoCellular Therapeutics to participate in the Southern California Investor Conference

Norovirus controlled on cruise ship Marco Polo with vaporisation process by Activ8

Survey aims to better understand daily needs of unpaid caregivers of people with diabetes

Common-sense precautions for H1N1

Improving the health and well-being of U.S. lesbian, gay, bisexual and transgender teens

Omnia Biologics and Aparna Biosciences sign agreement on lentivirus drug development

Neovasc reports Q2 2009 financials

The Parkinson's Disease Foundation and the Davis Phinney Foundation jointly fund new study

CEL-SCI expands work on current H1N1 virus vaccine

Pennsylvania Governor signs new emergency medical services law

Computed tomography angiography can identify abnormalities and injury beyond the pulmonary arteries

Message from The White House: The President is not backing away from the public plan

Seniors in U.S. overwhelmingly satisfied with their current Medicare coverage

New "micropatterning" method useful in gene expression studies

Depression causes reduced function in the reward center of brain

HealthFitness chosen to lead MillerCoor's health management strategy

Modular cleanrooms: Enhancing flexibility and compliance

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

Latest News